Syntimmune, Inc. clinical trials
Acquired by AstraZeneca, Jul 21, 2021 · source ↗
The registry lists 1 studies whose lead sponsor is Syntimmune, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 24, 2018.
- 1study on the registry
- 0open to participants now
Before and after it joined AstraZeneca
- First submitted before Syntimmune, Inc. became part of AstraZeneca
- 1
- First submitted after Syntimmune, Inc. became part of AstraZeneca
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Syntimmune, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Over the years
- 116
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Syntimmune, Inc.1 study
Something wrong with this grouping? Tell us on the AstraZeneca page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All AstraZeneca studies →
- A Study of SYNT001 in Healthy VolunteersCompletedNCT03643627Early Phase 1
Sponsor listed in the registry: Syntimmune, Inc. · First submitted before Syntimmune, Inc. became part of AstraZeneca